MIRA
INFORM REPORT
|
Report Date : |
27th
January, 2007 |
IDENTIFICATION
DETAILS
|
Name : |
BIORIGINAL INTERNATIONAL GROUP |
|
|
|
|
Registered Office : |
Industrial Zone C1, Plot No. 13, Ave
No. Xllli, Tenth of Ramadan City, Egypt. |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
2002 |
|
|
|
|
Com. Reg. No.: |
3451, Cairo |
|
|
|
|
Legal Form : |
Societe
Anonyme Egyptienne – SAE (Egyptian Joint Stock Company) |
|
|
|
|
Line of Business : |
Engaged in the manufacture of medical pharmaceuticals. |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
US$ 450,000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
|
Company
Name |
BIORIGINAL INTERNATIONAL GROUP |
|
Also Known As |
BIG PHARMA |
|
Country
of Origin |
Egypt |
|
Legal
Form |
Egyptian Joint Stock Company |
|
Registration
Date |
2002 |
|
Commercial
Registration Number |
3451, Cairo |
|
Issued
Capital |
£E 10,000,000 |
|
Paid
up Capital |
£E 10,000,000 |
|
Total
Workforce |
50 |
|
Line
of Business |
Manufacture of medical pharmaceuticals. |
|
Financial
Condition |
Fair |
|
Payments |
Nothing detrimental uncovered |
|
Operating
Trend |
Steady |
COMPANY NAME
BIORIGINAL INTERNATIONAL GROUP
ALSO KNOWN AS
BIG PHARMA
ADDRESS
Registered & Physical Address
Location : Industrial
Zone C1, Plot No. 13, Ave No. Xllli
Town : Tenth of Ramadan City
Country : Egypt
Telephone : (20-15) 386630
/ 386631 / 363500
Facsimile : (20-15) 386632
Email : info@bigpharmagroup.com
Premises
Subject
operates from a large suite of offices and a factory that are owned and located
in the Industrial Area of the Tenth of Ramadan City.
Branch Office (s)
Location Description
· 24 Abbas El Akad
Street Rented
sales office
Nasr
City
Cairo
Tel : (20-2) 2742805 / 2742820
Fax : (20-2) 2742721
KEY PRINCIPALS
· Dr. Mohamed Badawi Chairman
· Brigadier Mohamed
Hafez Managing
Director
·
Dr. Sayed
Hamza Director
· Dr. Magdy A. Shamaa Director
· Ayman Omar General
Manager
LEGAL FORM & OWNERS
Date of Establishment : 2002
Legal Form : Societe Anonyme Egyptienne – SAE (Egyptian Joint Stock Company)
Commercial Reg. No. : 3451, Cairo
Issued
Capital : £E 10,000,000
Paid
up Capital : £E 10,000,000
Name of Shareholder (s)
· Dr. Mohamed Badawi
· Brigadier Mohamed
Hafez
·
Dr. Sayed
Hamza
· Dr. Magdy A. Shamaa
· Egyptian businessmen & private
investors
Note to the Legal Form
The Egyptian Company Law provides that the capital of a Societe Anonyme Egyptienne - SAE – should not be less than £E 500,000 if shares are offered to the public and £E 250,000 if not. If shares are offered to the public they are freely transferable, if not, transfer may be restricted. Liability of shareholders is limited.
LINE OF BUSINESS
Operations
: Engaged in the manufacture of medical pharmaceuticals.
Import
Countries :
Italy and the United States of America
Operating
Trend : Steady
Subject
has a workforce of 50 employees.
FINANCIAL HIGHLIGHTS
Financial
highlights provided by outside sources are given below :
Currency
: Egyptian Pounds (£E)
Year
Ending 31/12/04: Year
Ending 31/12/05:
Total
Revenue £E
8,900,000 £E
10,200,000
Local
sources consider subject’s financial condition to be Fair.
BANKERS
·
National
Societe General Bank
5 Champollion Street
Cairo
Tel :
(20-2) 7707777
Fax :
(20-2) 7707799
PAYMENT HISTORY
No
complaints regarding subject’s payments have been reported.
GENERAL COMMENTS
Opinion
on the credit figure of US$ 100,000
During
the course of this investigation nothing detrimental was uncovered regarding
subject’s operating history or the manner in which payments are fulfilled. As
such the company is considered to be a fair trade risk and the above credit
figure is within subject’s financial means.
Maximum
suggested credit figure: US$ 450,000
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|